Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 20.94
IYH's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 20.94 )
Ranked among companies with meaningful P/E(ttm) only.
IYH' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 20.94
0
24.27
PE(NRI) 20.94
IYH's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 20.94 )
Ranked among companies with meaningful PE(NRI) only.
IYH' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 20.94
0
24.27
P/B 3.36
IYH's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 3.36 )
Ranked among companies with meaningful P/B only.
IYH' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.95
Current: 3.36
0
3.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.23
IYH's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.23 )
Ranked among companies with meaningful Dividend Yield only.
IYH' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.23
0
2.3
Yield on cost (5-Year) 2.23
IYH's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.23 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IYH' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.23
0
2.3

More Statistics

Short Percentage of Float0.00%
52-Week Range $130.63 - 157.13
Shares Outstanding (Mil)12,100,000.00
» More Articles for IYH

Headlines

Articles On GuruFocus.com
US Market Indexes Continue to Reach New Highs Dec 08 2016 
Southern Company: Dividend Achiever Nearing a 5% Yield Dec 08 2016 
Royce Funds: What's the Outlook for U.S. Small-Caps? Dec 08 2016 
Big Insider Sell at Apple, Buy at Acushnet Dec 08 2016 
Mason Hawkins Adds to FedEx Dec 08 2016 
Altria Group Announces Quarterly Dividend Dec 08 2016 
Jim Chanos Adds to Starz Dec 08 2016 
Lam Research Increases Dividend by a Solid 50% Dec 08 2016 
Avoid Advanced Micro Devices Dec 08 2016 
Lululemon Is a Buy Dec 08 2016 

More From Other Websites
Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares Dec 07 2016
The Fuel for Today’s Reflationary Fire: What You Need to Know Dec 02 2016
Which US Sectors Look Appealing in the Reflationary Environment? Dec 02 2016
These Pfizer Products Saw Falling Revenues in 3Q16 Nov 30 2016
Pfizer’s Innovative and Essential Health Businesses Nov 30 2016
Is Gilead Sciences Stock Oversold? Nov 28 2016
These Will Be the Challenges to BMY’s Opdivo in the Lung Cancer Space Nov 22 2016
Inside Bristol-Myers Squibb’s Upward Revision of Guidance Nov 22 2016
Inside Eli Lilly’s Revenue Trends Nov 22 2016
Opdivo’s Approval for Head and Neck Cancer: Another Feather in Bristol’s Cap? Nov 18 2016
What’s Bristol-Myers Squibb Stock Been Up To? Nov 18 2016
Ahead of Obamacare Open Enrollment, Are Health Care ETFs a Risk? Oct 25 2016
J&J Beats on Q3 Earnings: Should You Buy Healthcare ETFs? Oct 18 2016
3 ETFs to Buy if You Think Johnson & Johnson Will Beat Earnings Oct 17 2016
Four Key Deals: Analyzing Pfizer’s Impending Growth Oct 14 2016
Does Pfizer Deserve a Better Valuation? Oct 13 2016
How Large of a Role Does Opdivo Play in Bristol-Myers Squibb’s Success? Oct 12 2016
Bristol-Myers Squibb’s Strategies to Dominate Immuno-Oncology Market Oct 11 2016
Understanding the Recent Fall in Bristol-Myers Squibb’s Valuation Oct 07 2016
Shareholder Buyback: A Powerful Tool to Achieve Higher Income Oct 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK